|
|
|
| Year |
Name |
Title |
| 2022-2024 |
Natasha Marie Corbitt, MD, PhD
UT Southwestern
Dallas, TX |
Genetic and Cellular Drivers of Bile Duct Destruction in Biliary Atresia |
| 2022-2024 |
Jeong S. Hyun, MD
Stanford University
Stanford, CA |
Characterization of Fibrosis In Crohn’s Disease through Mesenteric Adipose Tissue |
| 2022-2024 |
Lisa M. McElroy, MD
Duke University
Durham, NC |
Creating a Multidimensional Data Architecture to Improve Equity in Organ Transplantation |
| 2021-2023 |
Filip Bednar, MD, PhD
Regents of the University of Michigan
Ann Arbor, MI |
Epigenetic Regulation of the Pancreatic Cancer Metabolism |
| 2021-2023 |
Neha Goel, MD
University of Miami
Miami, FL |
Characterizing the Impact of Genetic Ancestry and Multilevel Social Determinants of Health on Epigenomic Patterns and Signatures Driving Disparate Breast Cancer Outcomes |
| 2021-2023 |
Jesse D. Vrecenak, MD
Washington University in St. Louis
St. Louis, MO |
Gut-Directed In Utero Cellular Therapy for Cystic Fibrosis |
| 2020-2022 |
Ian E. Brown, MD, PhD
University of California Davis Medical Center
Sacramento, CA |
The Role and Regulation of P-selectin in Acute Pulmonary Arterial Thrombosis following Blunt Thoracic Trauma |
| 2020-2022 |
Eric G. Sheu, MD, PhD
Brigham and Women's Hospital
Boston, MA |
Characterization of a Novel, Gut-Restricted Metabolite That Links the Microbiome and the Anti-Diabetic Effects of Bariatric Surgery |
| 2020-2022 |
Heather Wachtel, MD
University of Pennsylvania
Philadelphia, PA |
Genomic Profiles and Targeted Therapy for Malignant Pheochromocytoma and Paraganglioma |
| 2019-2021 |
Rohit Chandwani, MD, PhD
Weill Cornell Medicine
New York, NY |
Memory of Inflammation in the Pre-Neoplastic Pancreas |
| 2019-2021 |
Jonathan D. Spicer, MD, PhD, FRCSC
Research Institute of the McGill University Health Center
Montreal, QC Canada |
Targeting Neutrophils as a Novel Therapeutic Adjuncts to the Treatment of Non-Small Cell Lung Cancer Patients |
| 2019-2021 |
David H. Stitelman, MD
Yale University
New Haven, CT |
Fetal Gene Editing for Hemoglobinopathies |
| 2018-2020 |
William H. Kitchens, Jr., MD, PhD
Emory University
Atlanta, Georgia |
Rap1-Interacting Adaptor Molecule (RIAM) as a New Target for Transplant Immunosuppression |
| 2018-2020 |
Colin A. Martin, MD
University of Alabama at Birmingham
Birmingham, Alabama |
Early Microbial Influence of IgA Secretion and Immune Development |
| 2018-2020 |
George Plitas, MD
Memorial Sloan Kettering Cancer Center
New York, New York |
CD177 Identifies a Novel Subset of Regulatory T Cells (Treg) Infiltrating Human Breast Cancer |
| 2017-2019 |
Matthew Delano, MD, PhD
University of Michigan
Ann Arbor, MI |
Immune Impact of Type 2 Diabetes Mellitus on Severe Sepsis Outcomes |
| 2017-2019 |
Joseph Scalea, MD
University of Maryland
Baltimore, MD |
Transplantation Tolerance without the Risks of Bone Marrow Transplantation: Eliminating the Need for Hematopoietic Stem Cells by Using Regulatory Myeloid Cells and Novel Biomarkers |
| 2017-2019 |
Mohamed Zayed, MD, PhD
Washington University School of Medicine
St. Louis, MO |
Targeting Diabetic Peripheral Arterial Disease Phospholipogenesis |
| 2016-2018 |
Vatche G. Agopian, MD
University of California, Los Angeles
Los Angeles, CA |
Molecular Analysis of Circulating Tumor Cells as a Prognostic Biomarker in Hepatocellular Carcinoma |
| 2016-2018 |
Genevieve M. Boland, MD
Massachusetts General Hospital
Boston, MA |
Analysis of Circulating Exosomes in Melanoma Responders/Non-responders to Immunotherapy |
| 2015-2017 |
Todd W. Costantini, MD
University of California San Diego
San Diego, CA |
A Human-Specific Mechanism Gauging Neuroinflammation and its Implications for Vagal
Nerve Therapeutics |
| 2015-2017 |
Paige Porrett, MD, PhD
University of Pennsylvania
Philadelphia, PA |
Genesis and Regulation of Pregnancy-induced Anti-fetal T cell Memory |
| 2015-2017 |
Brian R. Untch, MD
Memorial Sloan Kettering Cancer Center
New York, NY |
Adaptive and Acquired Resistance Mechanisms to the Therapeutic Targeting of Hras in Thyroid Cancer |
| 2014-2016 |
Karin M. Hardiman, MD, PhD
University of Michigan
Ann Arbor, Michigan |
Molecular Approaches to Improving Rectal Cancer Care |
| 2014-2016 |
Shirling Tsai, MD
University of Texas Southwestern Medical Center
Dallas, Texas |
Control of TGF-beta signaling by LRP1 in the pathogenesis of aortic aneurysms |
| 2014-2016 |
Daniel S. Eiferman, MD
Ohio State University
Columbus, Ohio |
Attenuation of Neuroinflammation by Methylene Blue Intervention in a Mouse Model of Traumatic Brain Injury |
| 2013-2015 |
Bao-Ngoc H. Nguyen, MD
George Washington University
Washington, DC |
The Role of Poly (Adp) Ribose Polymerase During Ischemic and Diabetic Wound Healing Process |
| 2013-2015 |
Kimberly J. Riehle, MD
University of Washington,
Seattle, Washington |
Improving Regeneration in the Fibrotic Liver |
| 2013-2015 |
Joseph J. Skitzki, MD
Roswell Park Cancer Institute,
Buffalo, New York |
Quinacrine for the Regional Therapy of Melanoma |
| 2012-2014 |
Ryan C. Fields, MD
Washington University School of Medicine
St. Louis, Missouri |
Advanced Genetic and Molecular Analysis of Metastatic Colorectal Cancer |
| 2012-2014 |
James J. Mezhir, MD
University of Iowa Hospitals and Clinics
Iowa City, Iowa |
Extracellular Superoxide Dismutase Alters the Tumor Microenvironment in Pancreatic Cancer |
| 2012-2014 |
Sunil Singhal, MD
University of Pennsylvania
Philadelphia, Pennsylvania |
Intraoperative Imaging of Lung Cancer |
| 2011-2013 |
Vishal Bansal, MD
University of California San Diego
San Diego, California |
Unlocking the healing potential of the central nervous system: The role of the vagus nerve following injury |
| 2011-2013 |
Bryan W. Tillman, MD, PhD
University of Pittsburgh
Medical Center
Pittsburgh, Pennsylvania |
Evaluating a Cell Specific Depletion Approach for Circulating Progenitor Cells in the Prevention of Late Vascular Graft Failure |
| 2011-2012 |
David G. Rabkin, MD
University of Washington
Medical Center
Seattle, Washington |
Cytokine removal by hemoadsorption after brain death; effect on ventricular function before and after orthotopic transplantation in a porcine model |
| 2010-2012 |
Eric C. Liao, MD
Massachusetts General Hospital
Boston, Massachusetts |
Application of Zebrafish Models of Cleft Lip and Palate as Whole-Organism Substrate for Drug Discovery |
| 2010-2012 |
Tippi C. MacKenzie, MD
University of California, San Francisco
San Francisco, California |
Maternal Immune Responses to Fetal Surgical Intervention |
| 2010-2012 |
Genevieve Melton-Meaux, MD
University of Minnesota
Minneapolis, Minnesota |
Application of Biomedical Informatics Technologies to the Electronic Health Record to Assess Gastrointestinal Surgical Patient Outcomes |
| 2009-2011 |
Jen Jen Yeh, MD
University of North Carolina
Chapel Hill, North Carolina |
Targeting the Ras-Ral GEF-Ral Pathway for Pancreatic Cancer Treatment |
| 2009-2011 |
James O. Park, MD
University of Washington
Seattle, Washington |
Glypican-3 Targeted Nanocarrier-mediated Contrast Magnetic Resonance Imaging Enhances Diagnosis of Indeterminant Hepatocellular Carcinoma Lesions |
| 2009-2011 |
Caprice Greenberg, MD
Brigham & Women’s Hospital
Boston, Massachusetts |
Institutional Variation in the Surgical Treatment of Early Stage Breast Cancer |
| 2008-2010 |
Jennifer F. Tseng, MD
University of Massachusetts Medical Center
Worcester, Massachusetts |
Neoadjuvant Strategies for Pancreatic Cancer: A Decision Analysis Model |
| 2008-2010 |
Rebecca A. Gladdy, MD, PhD
Mount Sinai Hospital
Toronto, Ontario |
Genetic Mechanisms of Sarcomagenesis |
| 2008-2010 |
Andrew M. Cameron, MD
Johns Hopkins School of Medicine
Baltimore, Maryland |
Prevention of Recurrent Hepatitis C After Liver Transplantation Using RNA Interference |
| 2007-2009 |
Michael J. Englesbe, MD
University of Michigan
Ann Arbor, Michigan |
Seasonal Variation in Surgical Quality at Teaching and Non-Teaching Medical Centers in the United States |
| 2007-2009 |
Robert W. O'Rourke, MD
Oregon Health & Sciences University
Portland, Oregon |
Immunologic Function in Obese Bariatric Surgery Patients |
| 2007-2009 |
Christopher Wolfgang, MD
Johns Hopkins School of Medicine
Baltimore, Maryland |
Targeting Lipid Mediations of Pancreatic Cancer Growth |
| 2006-2008 |
Marc G. Jeschke, MD, PhD
Shriners Burns Hospital for Children
Galveston, Texas |
Insulin Administration Improves Hepatic Structure and Function via The P13K/Adt/Wnt/B-catenin |
| 2006-2008 |
Christopher E. Touloukian, MD
Indiana University
Indianapolis, Indiana |
Enhancing Tumor Immunity by Altering Systemic Antigen Expression |
| 2005-2007 |
Christopher K. Breuer, MD
Yale University School of Medicine
New Haven, Connecticut |
Investigating the Growth Potential of Tissue Engineered Venous Conduits in a Juvenile Lamb Model |
| 2005-2007 |
Nita Ahuja, MD
Johns Hopkins Hospital
Division of Surgical Oncology
Baltimore, Maryland |
Methylation Profiles in Colorectal Cancer-Utility in Prognosis and Diagnosis |
| 2004-2006 |
John F. Renz, M.D.
New York Presbyterian Hospital
Center for Liver Disease and Transplantation
New York, New York |
The Effect of Heat Shock Protein Expression Upon the Immunogenicity of Human Hepatocellular Carcinoma |
| 2004-2006 |
Shahab A. Akhter, M.D.
University of Cincinnati College of Medicine
Cincinnati, Ohio |
The role of the Beta-Adrenergic Receptor Kinase in the Development of Hypertrophic Cardiomyopathy |
| 2003-2005 |
Daniel A. Saltzman, M.D.
University of Minnesota
Minneapolis, Minnesota |
Mechanisms of Tumor Prevention for Attenuated Salmonella |
| 2003-2005 |
James C. Y. Dunn, M.D.
UCLA School of Medicine
Los Angeles, California |
Intestinal Tissue Engineering for the Treatment of Short Bowel Syndrome |
| 2002-2004 |
Christopher R. Mantyh, M.D.
Duke University Medical Center
Durham, North Carolina |
Neurogenic Mechanisms of Chronic Colitis |
| 2002-2004 |
Herbert Chen, M.D.
University of Wisconsin Hospital
Madison, Wisconsin |
Gastrointestinal Neuroendocrine Tumors: A Possible Therapeutic Role for the RAS/RAF Signal Transduction Pathway |
| 2001-2003 |
Michael S. Mulligan, M.D.
University of Washington
Seattle, Washington |
Role of Chemokines in Ischemia Reperfusion of Lung |
| 2001-2003 |
James S. Allan, M.D.
Massachusetts General Hospital
Boston, Massachusetts |
The Role of MHC Allopeptides and Indirect Allo-recognition in the Pathogenesis of Chronic Lung Rejection |
| 2000-2002 |
Gilbert R. Upchurch, Jr., M.D.
University of Michigan School of Medicine
Ann Arbor, Michigan |
Activation of Matix Metalloproteinases During Aneurysm Formation is Nitric Oxide Dependent |
| 2000-2002 |
Robert C. Gorman, M.D.
Hospital University of Pennsylvania
Philadelphia, Pennsylvania |
Surgery for Post-Infarction Left Ventricular Remodelling |
| 1999-2001 |
Vivian Gahtan, M.D.
Yale University School of Medicine
New Haven, Connecticut |
Molecular Basis of Vascular Smooth Muscle Cell Migration: Thrombospondin-1 as a Paradigm |
| 1998-2000 |
John A. Goss, M.D.
Baylor College of Medicine
Houston, Texas |
Infectious Tolerance and Its Role in Intrathymic Tolerance |
| 1997-1999 |
Michael S. Conte, M.D.
Brigham and Women's Hospital
Boston, Massachusetts |
Endothelial Restoration and Vascular Remodeling |
| 1996-1998 |
Bruce R. Rosengard, M.D.
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania |
Two-Way Cell Trafficking and Microchimerism: Mechanisms of Rejection and Tolerance in Response to Solid Organ and Cellular Transplants |
| 1994-1996 |
Ronald J. Weigel, M.D., Ph.D.
Stanford University School of Medicine
Stanford, California |
Transcriptional Regulation of Estrogen Receptor in Breast Carcinoma |
| 1992-1994 |
Jonathan S. Bromberg, M.D., Ph.D.
University of Michigan Medical Center
Ann Arbor, Michigan |
Anti-CD2 and Anti-CD3 Monoclonal Antibodies Synergize to Prolong Allograft Survival with Decreased Side Effects |
| 1990-1992 |
B. Mark Evers, M.D.
University of Texas Medical Branch
Galveston, Texas |
Effect of GI Hormones on Growth of Normal and Neoplastic Gut Tissue |
| 1988-1990 |
Lawrence Rosenberg, M.D.
Montreal General Hospital
Montreal, Quebec, CANADA |
Islet Cell Differentiation in the Hamster Pancreas |
| 1986-1988 |
Ronald G. Tompkins, M.D.
Massachusetts General Hospital
Boston, Massachusetts |
Hybrid Artificial Liver Using Gel Entrapped Hepatocytes |
| 1984-1986 |
Michael E. Shapiro, M.D.
Beth Israel Deaconess Medical Center
Boston, Massachusetts |
Immune Regulation of Intraabdominal Abscesses |
| 1982-1984 |
Dana K. Andersen, M.D.
Yale University School of Medicine
New Haven, Connecticut |
Studies on the Pathophysiologic Role of Gastric Inhibitory Polypeptide (GIP) in Medically and Surgically Induced Changes in Glucose Metabolism |
